Faculty

Institution

Unit

Venue

Dawen Sui

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Statistical Analysis

The University of Texas MD Anderson Cancer Center

NoneDawen Sui is currently serving as a Statistical Analysis faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dawen Sui

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology immunology cancer research cancer care hematology dermatology cancer immunotherapy melanoma cancer treatment pathology pharmacology clinical research clinical transplantation cell transplantation immunotherapy medicinal research molecular cancer leukemia bone marrow transplantation thoracic oncology cancer biology transplantation medicine cellular therapy cancer genetics cancer management stem cell transplantation outcomes research breast cancer oncogenes medical mycology lymphoid neoplasia skin cancer hematological malignancies breast oncology sexual medicine reproductive health cancer cells clinical dermatology surgical oncology sexual health therapeutic efficacy clinical mycology lymphatic disease cancer genomics malignant blood disorders immune checkpoint inhibitors melanoma progression field trial cancer risk sex therapy tumor targeting myeloid neoplasia tumor suppressors cancer detection clinical immunology case studies randomized trial c-reactive protein acute myeloid leukemia metastatic nsclc clinical outcomes lymphatic system digital interventions relapse prevention health prevention tobacco use phase ii trial lymphomatoid papulosis brentuximab vedotin oncogene-specific differences tumor mutational burden former smokers inhibitor resistance reproductive health clinic comprehensive cancer center fda-approved 22c3

Notable Scholarly Works

Notable Federal Grants

Collaborators

1350P Immuno-Chemotherapy Alone for Laryngeal Cancer: Icolp Phase II Trial With 2-Year Follow-Up. Annals of Oncology (2025)

laryngeal cancerradiation oncologycancer careimmunotherapyneck oncologyjama oncologymedicinethoracic oncology2-year follow-upcancer treatmentclinical trialsoncology

63901 the Effect of Socioeconomic Status on Recurrence of Merkel Cell Carcinoma: A Propensity Score Matching Study. Journal of the American Academy of Dermatology (2025)

health policypublic healthepidemiologyhealth inequalitiessocial determinants of healthdisparitiesmerkel cell carcinomacancer disparitiessocial inequalityepidemiology of cancersocioeconomic statuscancer careoncology

Clinical Characteristics and Cancer Spectrum Among Breast Cancer Patients With Tp53 Germline Mutation From a Single Institution.. Journal of Clinical Oncology (2025)

breast oncologypathologyradiation oncologycancer spectrumsingle institutionbreast cancer patientscancer discoverycancer geneticscancer letteroncologybreast cancer

Pd-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients With Metastatic Nsclc at an Academic Medical Center, 2017–2021. Journal of Immunotherapy and Precision Oncology (2025)

clinical outcomesmetastasiscancer careprognosiscancer treatmentpd-l1 testinglung cancermedicinethoracic oncologyinternal medicinemetastatic nsclcurologypharmacotherapyclinical trialsoncology

Race-Associated Clinicogenomic Correlates of Outcomes to Immune Checkpoint Inhibitors Alone or With Chemotherapy in Non-Small Cell Lung Cancer (Nsclc).. Journal of Clinical Oncology (2025)

epidemiologycancer immunotherapyimmunologyimmunotherapylung cancermolecular diagnosticscancer genomicsthoracic oncologycheckpoint inhibitorsrace-associated clinicogenomic correlatesimmune checkpoint inhibitorsoncology

Race/Ethnicity Associated Clinicogenomic, Socioeconomic, and Environmental Predictors in Metastatic Non-Small Cell Lung Cancer (Mnsclc) Treated With Immunotherapy. International Journal of Cancer Care and Delivery (2025)

metastasisepidemiologyenvironmental predictorscancer immunotherapyimmunologyimmunotherapylung cancercancer disparitiesepidemiology of cancerthoracic oncologycancer careoncology

A Phase I Study of Nivolumab in Combination With Ipilimumab for the Treatment of Patients With High Risk or Refractory/Relapsed Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation. Blood (2024)

Gheath AlatrashCristina KnapeLaura WhitedDawen SuiCara L HaymakerJason YehMegan MarcotulliPariya SukhumalchandraLisa St. JohnHsinyi LuDaniela E. DuenasIgnacio WistubaJulia Mendoza PerezBeatriz Sanchez EspiridionRoland L. BassettTapan M. KadiaCourtney D. DiNardoFarhad RavandiJeremy RamdialRohtesh S. MehtaAmin M. AlousiBetul OranIssa F. KhouriQaiser BashirChitra HosingMuzaffar H. QazilbashJin S. ImPartow KebriaeiPavan BachireddyJeffrey J. MolldremJeffrey L. JorgensenSa A. WangWei WANGUday PopatElizabeth J. ShpallRichard E. ChamplinHagop M. KantarjianNaval Daver

malignant blood disordersstem-cell therapyhigh riskimmunologystem cellscell transplantationhematologybone marrow transplantationcancer treatmentacute myeloid leukemiamedicineclinical transplantationstem cell transplantationurologyleukemiaoncologymyeloid neoplasia

Lower Pg-Free Mel (Evomela) Clearance and Higher Exposure Are Associated With Better Treatment Response in Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy (2024)

Jitesh D. KawediaXiaoqian LiuDawen SuiAlison M. GulbisJeremy RamdialSamer A. SrourUday R. PopatYago NietoPartow KebriaeiNeeraj Y. SainiPaul LinYosra AljawaiOren PasvolskyHans C. LeeRobert Z. OrlowskiSheeba K. ThomasKrina K. PatelCristina KnapeRuby DelgadoRichard E. ChamplinElizabeth J. ShpallMuzaffar H. QazilbashPeter ThallQaiser Bashir

transplant surgeryimmunologybone marrow transplantationpharmacologymultiple myeloma patientstransplantation medicinehigher exposureorgan transplantationcancer immunotherapyhematologycancer treatmentlower pg-free melcell therapycellular therapytissue transplantationliver transplantationregenerative medicinecell transplantationmedicineclinical transplantationoncology

P-321 Daratumumab-Based Maintenance in Patients With Relapsed Multiple Myeloma After Salvage Autologous Hematopoietic Stem Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia (2024)

cell replacement therapiesp-321 daratumumab-based maintenanceimmunologycell transplantationhematological malignanciesimmunotherapyhematologybone marrow transplantationcellular therapyrelapsed multiple myelomamedicinestem cell transplantationoncology

A Phase 1 Dose Escalation Trial of Ex-Vivo Expanded Allogeneic Cord Blood–Derived Natural Killer Cell Immunotherapy for Pediatric Solid Tumor Malignancies.. Journal of Clinical Oncology (2023)

phase 1cell therapyallogeneic cordcancer immunotherapyimmunologycell transplantationdose escalation trialimmunotherapyhematologycellular therapymedicineexperimental medicineclinical trialsoncologymalignant blood disorders

1
2
3
4
5
8
10 / page

Dawen Sui

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Statistical Analysis

The University of Texas MD Anderson Cancer Center

NoneDawen Sui is currently serving as a Statistical Analysis faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dawen Sui

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

1350P Immuno-Chemotherapy Alone for Laryngeal Cancer: Icolp Phase II Trial With 2-Year Follow-Up. Annals of Oncology (2025)

laryngeal cancerradiation oncologycancer careimmunotherapyneck oncologyjama oncologymedicinethoracic oncology2-year follow-upcancer treatmentclinical trialsoncology

63901 the Effect of Socioeconomic Status on Recurrence of Merkel Cell Carcinoma: A Propensity Score Matching Study. Journal of the American Academy of Dermatology (2025)

Clinical Characteristics and Cancer Spectrum Among Breast Cancer Patients With Tp53 Germline Mutation From a Single Institution.. Journal of Clinical Oncology (2025)

breast oncologypathologyradiation oncologycancer spectrumsingle institutionbreast cancer patientscancer discoverycancer geneticscancer letteroncologybreast cancer

Pd-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients With Metastatic Nsclc at an Academic Medical Center, 2017–2021. Journal of Immunotherapy and Precision Oncology (2025)

clinical outcomesmetastasiscancer careprognosiscancer treatmentpd-l1 testinglung cancermedicinethoracic oncologyinternal medicinemetastatic nsclcurologypharmacotherapyclinical trialsoncology

Race-Associated Clinicogenomic Correlates of Outcomes to Immune Checkpoint Inhibitors Alone or With Chemotherapy in Non-Small Cell Lung Cancer (Nsclc).. Journal of Clinical Oncology (2025)

metastasisepidemiologyenvironmental predictorscancer immunotherapyimmunologyimmunotherapylung cancercancer disparitiesepidemiology of cancerthoracic oncologycancer careoncology

P-321 Daratumumab-Based Maintenance in Patients With Relapsed Multiple Myeloma After Salvage Autologous Hematopoietic Stem Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia (2024)

A Phase 1 Dose Escalation Trial of Ex-Vivo Expanded Allogeneic Cord Blood–Derived Natural Killer Cell Immunotherapy for Pediatric Solid Tumor Malignancies.. Journal of Clinical Oncology (2023)

1
2
3
4
5
8
10 / page